Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors

BACKGROUND: The modified Glasgow prognostic score (mGPS), a clinical tool that incorporates albumin and C‐reactive protein, has proven useful in the prognostication of multiple cancers. Several immune checkpoint inhibitors (ICIs) have been approved for the treatment of metastatic urothelial cell car...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Autores principales: Brown, Jacqueline T., Liu, Yuan, Shabto, Julie M., Martini, Dylan J., Ravindranathan, Deepak, Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Yantorni, Lauren Beth, Joshi, Shreyas S., Kissick, Haydn, Ogan, Kenneth, Harris, Wayne B., Carthon, Bradley C., Kucuk, Omer, Master, Viraj A., Bilen, Mehmet Asim
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Genitourinary Cancer
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100543/
https://ncbi.nlm.nih.gov/pubmed/33634507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13727
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares